Viatris Reports Q1 2026 Earnings and Financial Performance
Viatris (NASDAQ: VTRS) reported total revenues of $3.5 billion for the first quarter of 2026, reflecting a 3% growth driven by cardiovascular strength in Greater China and strong North America generics performance. Adjusted EBITDA reached $1 billion with 10% year-over-year growth.
Tickers: $VTRS